Enteral Collagen Peptide Protein Market Thumbnail Image

2021

Enteral Collagen Peptide Protein Market

Enteral Collagen Peptide Protein Market Size, Share, Competitive Landscape and Trend Analysis Report by Form, Age Group (Adults & Pediatrics and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

LS : Pharmaceuticals

Select an option
Author's: Sushant Terdale | Roshan Deshmukh
Publish Date:

Get Sample to Email

The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030. Collagen peptide protein is a protein derived from animal collagen. Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients who are unable to consume sufficient nutrients orally, but whose gastrointestinal function is in a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or has underwent surgery that may interfere with the normal eating process. In this process, collagen peptides protein is administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.

Rise in the prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in applications of collagen peptide protein in the healthcare sector are the major factors driving the growth of the global enteral collagen peptide protein market. Furthermore, increase in geriatric population along with favorable government initiates to promote healthy diet among population are expected to provide lucrative opportunities for existing players and new entrants. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide new avenues for the expansion of the global market during the forecast period.

Enteral-Collagen-Peptide-Protein-Market-2021-2030

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on enteral collagen peptide protein market, owing to decline in meat consumption, especially marine and bovine products, across the globe. This factor has directly impacted the production of collagen peptides, as fish and beef wastes are major raw materials for collagen products. In addition, business collaborations and partnership opportunities for enteral collagen peptide protein are negatively affected by COVID-19 outbreak, which led to decline in the enteral collagen peptide protein products production. Thus, the enteral collagen peptide protein market has been negatively impacted due to the current global health crisis

Enteral Collagen Peptide Protein Market Segmentation  

The global enteral collagen peptide protein market is segmented into form, age group, end user, and region. On the basis of form, the enteral collagen peptide protein market is bifurcated into powder and liquid. By age group, it is classified into adults (above 18) and pediatrics (below 18). Depending on end user, it is fragmented into hospitals & clinics, homecare, and nursing home. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Segment review 

On the basis of form, the liquid segment is the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in the demand and consumption of enteral supplements that come in the form of liquid, due to increase in availability of liquid enteral collagen peptide protein products and rise in health concerns among consumers.

Enteral Collagen Peptide Protein Market
By Form
Your browser does not support the canvas element.

Liquid segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

On the basis of age group, the adult (above 18 years) segment was the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to higher number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. Furthermore, increase in geriatric population that requires enteral collagen peptide protein and has difficulty in swallowing is expected to contribute toward the market growth.

Enteral Collagen Peptide Protein Market
By Age Group
Your browser does not support the canvas element.

Age Group Segment hold the dominant position and would continue to maintain the lead over the forecast period.

By end user, the homecare segment is the major shareholder in the enteral collagen protein peptide market, owing to increase in number of patients adopting enteral collagen peptide protein products administration at home and increase in demand for home care enteral collagen peptide protein treatment. 

Enteral Collagen Peptide Protein Market
By End User
Your browser does not support the canvas element.

Home Care Segment hold the dominant position and would continue to maintain the lead over the forecast period.

Snapshot of Asia-Pacific enteral collagen peptide protein market  

Asia-Pacific presents lucrative opportunities for key players operating in the enteral collagen peptide protein market, owing to increase in geriatric population, R&D investments in developments of collagen peptide protein products for various chronic diseases, supportive government initiatives directed toward the reduction of the malnutrition deficiency, and significant surge in demand for advanced healthcare facilities.

Enteral Collagen Peptide Protein Market
By Country
2030
Europe 
North America
Asia-Pacific
LAMEA

Asia Pacific exhibit the highest CAGR of 9.2 % during 2021-2030

Moreover, rise in number of people suffering from arthritis disease and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share are expected to drive growth of the enteral collagen peptide protein market in the region.

The key players profiled in this report include Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medline Industries, Inc, Global Health Products, Inc., OP2 labs, LLC, fresenius Kabi AG, Gelita AG, and Weishardt Holding SA.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the enteral collagen peptide protein market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers enteral collagen peptide protein market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global enteral collagen peptide protein market growth.

Key Market Segments

By Form

  • Powder
  • Liquid

By Age Group

  • Adults (Above 18)
  • Pediatrics (Below 18)

By End User

  • Hospitals & Clinics
  • Homecare
  • Nursing Home

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Enteral Collagen Peptide Protein Market Report Highlights

Aspects Details
icon_5
By FORM
  • Powder
  • Liquid
icon_6
By AGE GROUP
  • Adults (above18)
  • Pediatric (below 18 years)
icon_7
By END USER
  • Hospitals & clinics
  • Homecare
  • Nursing home
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_9
Key Market Players

GLOBAL HEALTH PRODUCTS, INC., MEDTRITION INC., MEDLINE INDUSTRIES, INC., WEISHARDT HOLDING SA, .FRESENIUS KABI AG, ABBOTT LABORATORIES, DANONE S.A. (NUTRICIA), DERMARITE INDUSTRIES LLC, GELITA AG, OP2 LABS LLC

Analyst Review

Enteral collagen peptide protein is recommended for patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. In enteral feeding system, nutrition or medications are directly administered in the stomach or intestine.

Factors such as rise in sale of enteral collagen peptide protein products, consumer focus on protein-rich diets, and rise in use of collagen peptide protein in the healthcare industry due to their high protein content drive the growth of market. In addition, increase in investment in R&D activities to develop innovative products and rise in number of malnutrition cases drives the growth of the market. Moreover, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth during the forecast period.

Author Name(s) : Sushant Terdale | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Enteral Collagen Peptide Protein Market is $ 25,811 Thousand in 2020

The forecast period in the report is from 2021 to 2030

The market value of Enteral Collagen Peptide Protein in 2020 was 14,586 Thousand

The base year for the report is 2020

Yes, Enteral Collagen Peptide Protein Market companies are profiled in the report

The top companies that hold the market share in Enteral Collagen Peptide Protein Market are are Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medlin Industries

No, there is no value chain analysis provided in the Enteral Collagen Peptide Protein Market report

The key trends in the Enteral Collagen Peptide Protein Market are increase in number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis and increase in demand for home care enteral collagen peptide protein treatment

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Enteral Collagen Peptide Protein Market

Global Opportunity Analysis and Industry Forecast, 2021-2030